<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Following the use of deep hypothermic <z:e sem="disease" ids="C0444720" disease_type="Disease or Syndrome" abbrv="">circulatory arrest</z:e> in cardiac surgery, cerebral blood flow and cerebral oxygen metabolism are impaired </plain></SENT>
<SENT sid="1" pm="."><plain>These may result from abnormal <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Powerful vasoconstrictors including endothelins and <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi> could mediate these processes </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated possible involvement of these two factors by assessing the effects of (a) phosphoramidon-an inhibitor of endothelin converting enzyme, and (b) vapiprost (GR32191B)-a specific <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi>-receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, on the recovery of cerebral blood flow and cerebral oxygen metabolism following deep hypothermic <z:e sem="disease" ids="C0444720" disease_type="Disease or Syndrome" abbrv="">circulatory arrest</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: A total of 18 1-week-old piglets were randomised into three groups (n = 6 per group) </plain></SENT>
<SENT sid="5" pm="."><plain>At induction, the control group received saline; group PHOS received phosphoramidon 30 mg kg-1 intravenously </plain></SENT>
<SENT sid="6" pm="."><plain>Group VAP received vapiprost 2 mg kg-1 at induction and at 30 min intervals thereafter </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> groups underwent cardiopulmonary bypass cooling to 18 degrees C, exposed to 60 min of deep hypothermic <z:e sem="disease" ids="C0444720" disease_type="Disease or Syndrome" abbrv="">circulatory arrest</z:e>, rewarmed and reperfused for 1 h </plain></SENT>
<SENT sid="8" pm="."><plain>Cerebral blood flow was measured with radio-labeled microspheres: cerebral oxygen metabolism was calculated at baseline before deep hypothermic <z:e sem="disease" ids="C0444720" disease_type="Disease or Syndrome" abbrv="">circulatory arrest</z:e> and at 1 h of reperfusion and rewarming </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: In the control group, cerebral blood flow decreased to 40.2 +/- 2.0% of baseline after deep hypothermic <z:e sem="disease" ids="C0444720" disease_type="Disease or Syndrome" abbrv="">circulatory arrest</z:e> and cerebral oxygen metabolism decreased to 50.0 +/- 5.5% (P &lt; 0.0005) </plain></SENT>
<SENT sid="10" pm="."><plain>The responses in group PHOS were similar </plain></SENT>
<SENT sid="11" pm="."><plain>In group VAP, cerebral blood flow and cerebral oxygen metabolism were 64.3 +/- 10.6 and 80.1 +/- 9.8% of baseline, respectively, after deep hypothermic <z:e sem="disease" ids="C0444720" disease_type="Disease or Syndrome" abbrv="">circulatory arrest</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Thus, treatment with vapiprost significantly improved recovery of cerebral blood flow (P = 0.046) and cerebral oxygen metabolism (P = 0.020) following deep hypothermic <z:e sem="disease" ids="C0444720" disease_type="Disease or Syndrome" abbrv="">circulatory arrest</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>No such improvement was seen after treatment with phosphoramidon </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="15627">Thromboxane A2</z:chebi> mediates impairments in cerebral perfusion and metabolism following deep hypothermic <z:e sem="disease" ids="C0444720" disease_type="Disease or Syndrome" abbrv="">circulatory arrest</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>These changes were attenuated by blockade of <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi>-receptors using vapiprost </plain></SENT>
<SENT sid="16" pm="."><plain>Endothelins are not shown to be involved </plain></SENT>
<SENT sid="17" pm="."><plain>Better knowledge of injury mechanisms will enable development of more effective cerebral protection strategies and allow safer application of deep hypothermic <z:e sem="disease" ids="C0444720" disease_type="Disease or Syndrome" abbrv="">circulatory arrest</z:e> </plain></SENT>
</text></document>